An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation
H. Asakura et al., An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation, CRIT CARE M, 29(6), 2001, pp. 1164-1168
Objectives: To investigate the relationship between fibrinolytic enhancemen
t and the development of multiple organ failure (MOF) in disseminated intra
vascular coagulation (DIC). To detect the useful prognostic index for outco
me in DIG.
Design: Case-control study.
Setting: A department of internal medicine in a university hospital, a clin
ical division for diagnosis and treatment, mainly of respiratory diseases,
hematologic diseases, DIG, and other diseases requiring critical care medic
ine.
Patients: A total of 69 DIC patients, 31 with MOF.
Interventions: None.
Measurement and Main Results: The DIC patients with MOF had more elevated l
evels of tissue plasminogen activator antigen (t-PA) and plasminogen activa
tor inhibitor antigen (PAI), and more depressed levels of plasmin-alpha2 pl
asmin inhibitor complex (PIC) and fibrin/fibrinogen degradation products th
an those without MOF, although no significant difference in thrombin-anithr
ombin complex (TAT) levels was observed. A fibrinolytic enhancement (shown
by PIG) was parallel to an activation of blood coagulation (shown by TAT) i
n DIC patients without MOF, although no such fibrinolytic enhancement was p
rovoked even by much activation of blood coagulation in DIC patients with M
OF. Whereas all the patients without MOF were restored from DIG, 14 of 31 p
atients with MOF were unable to be restored from DIC and died. A significan
t increase in plasma levels of t-PA and PAI under the condition of sustaine
d hemostatic activation was observed in the patients who died.
Conclusion: Enhanced fibrinolysis was considered to be the important defens
e mechanism in preventing the development of MOF in DIG. The increases in p
lasma levels of t-PA and PAI were poor prognostic markers in DIG. Further c
areful study may be useful to clarify whether the fibrinolytic therapy is b
eneficial in clinical DIC patients with MOF.